Adrenal Tumor Clinical Trial
Official title:
Is There Anything New in the Field of Large Adrenal Tumors ?
Laparoscopic adrenalectomy is the treatment of choice for the benign tumor of less than 6 cm. However, this is an ongoing debate that exact cut-off value of tumor size for LA. The aim of this study was to assess whether the size of the adrenal tumor affects preoperative and postoperative outcomes in patients undergoing laparoscopic transperitoneal adrenalectomy as well as to evaluate the learning curve.
From April 2010 to October 2018, preoperative and postoperative data of 107 patients who
underwent LTA with adrenal mass were recorded prospectively and analyzed retrospectively.
The inclusion criteria were all hormonally active adrenal lesions, detection of increases in
size in < 4 cm adrenal tumors on serial imaging, solitary adrenal metastases without evidence
of local invasion, tumors size ≥ 4 cm, patients between the age of 18 and 80, and American
Society of Anesthesiologists score (ASA) ≤ 3. The patients with adrenal masses that specified
suspicion of malignancy on imaging such as local invasion, irregular tumor margins were
evaluated as ineligible for LTA, and excluded in this study, were addressed to open surgery.
Retroperitoneoscopic and laparoscopic partial adrenalectomies were also excluded from the
study.
Totally 102 patients were included in the study. The patients were allocated according to
adrenal tumor size as <6cm (group 1:76) and ≥ 6 cm (group 2: 26). The variables such as
demographics, tumor size, and laterality, operation time, blood loss, per-operative and
postoperative complications, length of hospital stay, final pathology result were compared
between the two groups. In order to evaluate the learning curve, the patients were also
classified into three consecutive groups including group A (1-25), group B (25-50), group C
(51-75) and group D (76-102) according to the chronological order of their surgery. Variables
including operation time, tumor size, blood loss, and hospital stay, and overall
complications were used to investigate the learning curve.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06050057 -
Surgical Treatment of Adrenal Diseases- Laparoscopic vs. Robotic-assisted Adrenalectomy
|
||
Completed |
NCT06330558 -
Side-specific Factors for Conversion in Adrenalectomy for Pheochromocytoma.
|
||
Completed |
NCT04071561 -
Prevention of Conversion in Posterior Retroperitoneal Adrenalectomy by Measuring Preoperative Anatomical Conditions
|
||
Recruiting |
NCT06229405 -
Development of Clinical Evidence for Optimal Management of Adrenal Diseases Based on Real-World Data
|
||
Completed |
NCT00454103 -
Evaluation of 123I-Iodometomidate for Adrenal Scintigraphy
|
Phase 1/Phase 2 | |
Completed |
NCT03469102 -
18FDG PET Textural Indices in Adrenal Lesion
|
||
Completed |
NCT01959711 -
Randomized Clinical Trial of Posterior Retroperitoneoscopic Adrenalectomy Versus Lateral Laparoscopic Adrenalectomy
|
Phase 4 | |
Recruiting |
NCT04127552 -
Impact of Adrenal IncidenTalomas and Possible Autonomous Cortisol Secretion on Cardiovascular and Metabolic Alterations
|
||
Recruiting |
NCT04905706 -
3D Laparoscopic Adrenalectomies for Adrenal Tumors
|
||
Recruiting |
NCT05739812 -
The Efficacy and Safety of Chinese Domestic Surgical Robot System in Urological Telesurgery
|
N/A | |
Completed |
NCT03739918 -
Rare Cystic Benign Adrenal Incidentalomas
|
||
Completed |
NCT04804163 -
Research on the Effectiveness and Safety of Remote Control of Domestic Surgical Robot System for Urinary Surgery
|
Early Phase 1 | |
Completed |
NCT03327142 -
EUS-guided FNA in the Study of the Adrenal Gland
|
N/A | |
Completed |
NCT04570176 -
Efficacy and Safety of Clinical Telesurgery Using Chinese Independently Developed Surgical Robot System
|
N/A | |
Not yet recruiting |
NCT04432532 -
Neuroendocrine and Adrenal Tumors
|